These effects, together with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 aid the thought of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-related disorders. Gene expression analysis unveiled that ACKR3 https://cruzfuwvo.blogpixi.com/32744879/conolidine-for-dummies